XML 16 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities    
Net income $ 1,623 $ 1,169
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:    
Depreciation and amortization 111 106
Noncash lease expense 32 43
Stock-based compensation 176 165
Deferred income tax expense (benefit) (41) 53
Other investment gains (24) 0
Net (gains) losses within CIPs (104) (88)
Net (purchases) proceeds within CIPs (989) (477)
(Earnings) losses from equity method investees (48) (40)
Distributions of earnings from equity method investees 8 8
Changes in operating assets and liabilities:    
Accounts receivable (73) (270)
Investments, trading (9) 2
Other assets (796) (696)
Accrued compensation and benefits (1,339) (1,243)
Accounts payable and accrued liabilities 196 (91)
Other liabilities 869 965
Net cash provided by/(used in) operating activities (408) (394) Close
Investing activities    
Purchases of investments (324) (318)
Proceeds from sales and maturities of investments 210 142
Distributions of capital from equity method investees 162 8
Net consolidations (deconsolidations) of sponsored investment funds (6) 27
Purchases of property and equipment (64) (81)
Net cash provided by/(used in) investing activities (22) (222) Close
Financing activities    
Repayments of long-term borrowings (1,000) 0
Proceeds from long-term borrowings 2,979 0
Cash dividends paid (795) (796)
Proceeds from stock options exercised 144 27
Repurchases of common stock (634) (721)
Net proceeds from (repayments of) borrowings by CIPs (14) (19)
Net subscriptions received/(redemptions/distributions paid) from noncontrolling interest holders 430 305
Other financing activities (15) 10
Net cash provided by/(used in) financing activities 1,095 (1,194) Close
Effect of exchange rate changes on cash, cash equivalents and restricted cash (27) 38 Close
Net increase/(decrease) in cash, cash equivalents and restricted cash 638 (1,772) Close
Cash, cash equivalents and restricted cash, beginning of period 8,753 7,433
Cash, cash equivalents and restricted cash, end of period 9,391 5,661
Supplemental schedule of noncash investing and financing transactions:    
Issuance of common stock 392 510
Increase (decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds $ (353) $ (5)